FIELD: pharmacology.
SUBSTANCE: invention relates to a means for treatment of toxic encephalopathy caused by carbon monoxide containing synergistically acting components: a delta-sleep inducing peptide with the Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu sequence, sodium nucleospermate, carnosine dipeptide and amino acid glycine, at a weight ratio of 1:(1-100):(1-100):(1-100), respectively.
EFFECT: improved perception of information, reduced memory impairments and cognitive disorders in the remote period of intoxication and prevention of long-term effects of central nervous system damage during carbon monoxide poisoning.
3 cl, 1 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TOOLS FOR CORRECTING THE DESYNCHRONOSIS CAUSED BY A DISTURBANCE IN THE LIGHT REGIME | 2017 |
|
RU2660578C1 |
| AGENT FOR DISEASES ASSOCIATED WITH STRESS-RELATED CONDITIONS IN DISEASES AND DISORDERS IN HUMAN AND ANIMALS, AND ALSO METHOD OF TREATING AND/OR PREVENTING WITH USING SUCH AGENT | 2009 |
|
RU2450823C2 |
| USING DELTA SLEEP INDUCING PEPTIDE FOR HEPATOPROTECTIVE EFFECT IN CHRONIC IMMOBILISATION STRESS | 2013 |
|
RU2538686C1 |
| USING DELTA-SLEEP INDUCING PEPTIDE FOR HEPATOPROTECTIVE ACTION IN CHRONIC EMOTIONAL PAIN STRESS | 2013 |
|
RU2537032C2 |
| AGENT FOR BURN DISEASE TREATMENT | 1993 |
|
RU2070054C1 |
| DIAGNOSTIC TECHNIQUE FOR MERCURY ENCEPHALOPATHY IN SMALL LABORATORY ANIMALS | 2011 |
|
RU2471247C1 |
| TETRAPEPTIDE STIMULATING FUNCTIONAL ACTIVITY OF NEURONS, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USE | 1999 |
|
RU2155063C1 |
| PEPTIDES SHOWING ANTISTRESS, ANTICONVULSANT AND NEUROPROTECTIVE EFFECT | 1997 |
|
RU2115660C1 |
| REMEDY FOR POISONING AND ITS COMPLICATIONS TREATMENT | 2006 |
|
RU2331417C1 |
| ANTISTRESS AND NOOTROPIC PREPARATION OF ANTIVIRAL AND IMMUNOSTIMULATING ACTION | 2001 |
|
RU2211703C2 |
